FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

254011000001107: Solian 400 tablets (Sanofi-Synthelabo Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16999101000001118 Solian 400 tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66012501000001119 Solian 400 tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Solian 400 tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely amisulpride 400 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Has active ingredient Amisulpride false Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Is a Solian true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Amisulpride true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Solian 400 tablets (Sanofi-Synthelabo Ltd) 60 tablet 4 x 15 tablets Is pack of False Solian 400 tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Solian 400 tablets (Sanofi-Synthelabo Ltd) 60 tablet 4 x 15 tablets Has AMP True Solian 400 tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start